Le Lézard
Classified in: Health, Science and technology
Subject: VET

Operation 11/11 Gives Veterans Concierge-Level Health Care at No Cost on Veterans Day


AUSTIN, Texas, Oct. 15, 2019 /PRNewswire/ -- Medici, a virtual health care company, announced today the launch of Operation 11/11, a new initiative providing virtual consults across multiple specialties to all U.S. veterans on Veterans Day, November 11.

Medici Logo

During Operation 11/11, all veterans who register at Medici will have access to text, voice or video consultations with doctors specializing in general practice, psychiatry, dermatology, orthopedics and more. With this access, veterans can receive expert advice, diagnosis, prescriptions or referrals to other specialists. Proof of military service is required, although health insurance is not needed.

"Veterans Day is not about furniture and car sales. It is about recognizing the extraordinary service of our veterans," says Clint Phillips, founder and CEO of Medici. "We can think of no better way to thank our veterans than to provide them with concierge-level care across multiple specialties without leaving their homes."

Access to care will be provided using Medici's simple-to-use virtual care app, which connects users directly with doctors. Veterans can pre-register now at https://www.medici.md/veterans for zero cost across multiple specialties on Veterans Day from 8 am to 8 pm for each U.S. time zone.

Military heroes support Operation 11/11
In addition to announcing Operation 11/11, Medici is welcoming four military heroes as advisors of the new initiative, including:

"Having these military heroes come alongside us and tell us that the work we are doing is life-changing is all the validation we needed to dedicate all our resources to this initiative," said Phillips. "Operation 11/11 allows us and hundreds of remarkable doctors the opportunity to give back to those who deserve it most."

Medici has also partnered with 2nd.MD, which provides access to the world's leading specialists across 130 subspecialties at the top U.S. hospitals. A limited number of veterans with complex cases will be able to have virtual second opinions thanks to 2nd.MD.

About Medici
Medici is working to change how health care is delivered by recreating the doctor-patient relationship. With the secure messaging app, physicians and patients can connect via text, call or video from anywhere and on their schedule. This enables patients to chat with their doctor, vet or therapist at any time, and clinicians to extend care and get paid without extra overhead or burdensome schedules. With over 20,000 doctors across all platforms, Medici is leading the way in the future of health care. For more information, visit http://www.medici.md.

Media Contact:
Heidi McDow, 972-267-1111
[email protected]

SOURCE Medici


These press releases may also interest you

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping...

at 02:59
Immunovia (STOCKHOLM: IMMNOV), the diagnostics company seeking to increase pancreatic cancer survival through early detection, today offers an update on its new lab in Research Triangle Park, USA.  Immunovia announced on 29 April the company's...

at 02:23
Sobi® today announced the initiation of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for SEL-212. The submission is based on the results of the DISSOLVE I and II pivotal studies. SEL-212 is an...

at 02:00
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to deliver genomic profiles of fetal cells that is highly concordant with the genomic analysis obtained from...

at 01:35
4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment of Luc Boblet as Chief Executive Officer. The company, having successfully completed its...

at 01:00
 Decision adds to existing collaboration agreement with Exelixis, permitting Ipsen to seek potential marketing authorizations for Cabometyx® (cabozantinib) in advanced pancreatic and extra pancreatic neuroendocrine tumors outside of the U.S. and...



News published on and distributed by: